Trials / Unknown
UnknownNCT01748903
TARGET Intracranial Aneurysm Coiling Registry
TARGET Intracranial Aneurysm Coiling Registry: A Prospective Clinical Efficacy and Safety Study of Stryker Target® 360°, Target® Helical, and 2nd Generation Target® Nano Coils
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Mercy Health Ohio · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Target 360°, 2D Coils, Nano Coils |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2019-01-01
- Completion
- 2019-03-01
- First posted
- 2012-12-13
- Last updated
- 2018-07-24
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01748903. Inclusion in this directory is not an endorsement.